Roger Lewis White

Title
InstitutionMedical University of South Carolina
DepartmentCOP Clinical Pharmacy and Outcome Sciences - MUSC Campus
AddressP.O. Box MSC140
QF219
280 Calhoun St.
Phone843-792-8462
Fax843-792-1712
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Enzweiler KA, Bosso JA, White RL. A novel method of estimating cost of therapy by using patient population characteristics: analysis of fluoroquinolones in various populations with different distributions of renal function. Pharmacotherapy. 2003 Jul; 23(7):925-32. PMID: 12885105.
      Citations:    
    2. White RL, Bonapace CR, Friedrich LV, Rybak MJ, Cappelletty DM, Mercier RC, Houlihan HH, Aeschlimann JR, Bosso JA. Assessment of differences in antimicrobial effect determined with two in vitro pharmacodynamic models: impact of surface area to volume ratio. Pharmacotherapy. 2003 May; 23(5):603-8. PMID: 12741434.
      Citations:    
    3. Bonapace CR, Bosso JA, Friedrich LV, White RL. Comparison of methods of interpretation of checkerboard synergy testing. Diagn Microbiol Infect Dis. 2002 Dec; 44(4):363-6. PMID: 12543542.
      Citations:    
    4. Bonapace CR, Friedrich LV, Bosso JA, White RL. Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection. Antimicrob Agents Chemother. 2002 Nov; 46(11):3574-9. PMID: 12384367.
      Citations:    
    5. Bonapace CR, White RL, Frich LV, Bosso JA. Differences in antimicrobial drug exposure in patients with various degrees of renal function based on recommendations from dosing references. Pharmacotherapy. 2002 Sep; 22(9):1097-104. PMID: 12222544.
      Citations:    
    6. White RL, Enzweiler KA, Friedrich LV, Wagner D, Hoban D, Bosso JA. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000. Diagn Microbiol Infect Dis. 2002 Jul; 43(3):207-17. PMID: 12106954.
      Citations:    
    7. White RL. Antibiotic resistance: where do ketolides fit? Pharmacotherapy. 2002 Jan; 22(1 Pt 2):18S-29S; discussion 30S-32S. PMID: 11791625.
      Citations:    
    8. White RL. What in vitro models of infection can and cannot do. Pharmacotherapy. 2001 Nov; 21(11 Pt 2):292S-301S. PMID: 11714221.
      Citations:    
    9. White RL, Friedrich LV, Burgess DS, Brown EW, Scott LE. Effect of removal of duplicate isolates on cumulative susceptibility reports. Diagn Microbiol Infect Dis. 2001 Apr; 39(4):251-6. PMID: 11404069.
      Citations:    
    10. White RL, Friedrich LV, Manduru M, Mihm LB, Bosso JA. Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis. Diagn Microbiol Infect Dis. 2001 Jan; 39(1):39-47. PMID: 11173190.
      Citations:    
    11. Bonapace CR, White RL, Friedrich LV, Bosso JA. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagn Microbiol Infect Dis. 2000 Sep; 38(1):43-50. PMID: 11025183.
      Citations:    
    12. White RL, Friedrich LV, Mihm LB, Bosso JA. Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas. Clin Infect Dis. 2000 Jul; 31(1):16-23. PMID: 10913390.
      Citations:    
    13. Bonapace CR, White RL, Friedrich LV, Norcross ED, Bosso JA. Pharmacokinetics of cefepime in patients with thermal burn injury. Antimicrob Agents Chemother. 1999 Dec; 43(12):2848-54. PMID: 10582870.
      Citations:    
    14. Bosso JA, Bonapace CR, Flume PA, White RL. A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis. Pharmacotherapy. 1999 May; 19(5):620-6. PMID: 10331825.
      Citations:    
    15. Friedrich LV, White RL, Bosso JA. Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes. Clin Infect Dis. 1999 May; 28(5):1017-24. PMID: 10452628.
      Citations:    
    16. Manduru M, Mihm LB, White RL, Friedrich LV, Flume PA, Bosso JA. Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method. Antimicrob Agents Chemother. 1997 Nov; 41(11):2527-32. PMID: 9371361.
      Citations:    
    17. Manduru M, Mihm LB, White RL, Friedrich LV, Flume PA, Bosso JA. In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother. 1997 Sep; 41(9):2053-6. PMID: 9303416.
      Citations:    
    18. Manduru M, Fariello A, White RL, Fox JL, Bosso JA. Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution. Am J Health Syst Pharm. 1996 Nov 15; 53(22):2731-4. PMID: 8931816.
      Citations:    
    19. Berg PH, Voit EO, White RL. A pharmacodynamic model for the action of the antibiotic imipenem on Pseudomonas aeruginosa populations in vitro. Bull Math Biol. 1996 Sep; 58(5):923-38. PMID: 8837524.
      Citations:    
    20. White RL, Burgess DS, Manduru M, Bosso JA. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother. 1996 Aug; 40(8):1914-8. PMID: 8843303.
      Citations:    
    21. Nicolau DP, White RL, Friedrich LV, Kays MB. The costs of burn care: an analysis with an emphasis on the use of parenteral antimicrobials. J Burn Care Rehabil. 1994 May-Jun; 15(3):244-50. PMID: 8056815.
      Citations:    
    22. White RL, Kays MB, Friedrich LV, Del Bene VE. Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycins. J Antimicrob Chemother. 1993 Jan; 31(1):57-64. PMID: 8444675.
      Citations:    
    23. Friedrich LV, White RL, Kays MB, Burgess DS. Pharmacoeconomic evaluation of treatment of penetrating abdominal trauma. Am J Hosp Pharm. 1992 Mar; 49(3):590-4. PMID: 1598932.
      Citations:    
    24. Kays MB, White RL, Gatti G, Gambertoglio JG. Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations. Pharmacotherapy. 1992; 12(1):50-5. PMID: 1549539.
      Citations:    
    25. Kays MB, White RL, Friedrich LV, Del Bene VE. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties. Clin Ther. 1991 Sep-Oct; 13(5):596-605. PMID: 1799917.
      Citations:    
    26. Uber WE, Brundage RC, White RL, Brundage DM, Bromley HR. In vivo inactivation of tobramycin by piperacillin. DICP. 1991 Apr; 25(4):357-9. PMID: 1926903.
      Citations:    
    27. White RL, Kays MB, Friedrich LV, Brown EW, Koonce JR. Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels. J Clin Microbiol. 1991 Feb; 29(2):398-400. PMID: 1822083.
      Citations:    
    28. Friedrich LV, White RL, Kays MB, Brundage DM, Yarbrough D. Aztreonam pharmacokinetics in burn patients. Antimicrob Agents Chemother. 1991 Jan; 35(1):57-61. PMID: 2014982.
      Citations:    
    29. Friedman RJ, Friedrich LV, White RL, Kays MB, Brundage DM, Graham J. Antibiotic prophylaxis and tourniquet inflation in total knee arthroplasty. Clin Orthop Relat Res. 1990 Nov; (260):17-23. PMID: 2121406.
      Citations:    
    30. White RL, Kays MB, Armstrong TA, Friedrich LV. Effects of supraphysiologic temperature and broth dilution on serum protein binding. Antimicrob Agents Chemother. 1990 Jun; 34(6):1257-8. PMID: 2393287.
      Citations:    
    31. Friedrich LV, White RL, Brundage DM, Kays MB, Friedman RJ. The effect of tourniquet inflation on cefazolin tissue penetration during total knee arthroplasty. Pharmacotherapy. 1990; 10(6):373-7. PMID: 2287555.
      Citations:    
    32. Friedrich LV, White RL, Reboli AC. Pharmacodynamics of trimethoprim-sulfamethoxazole in Listeria meningitis: a case report. Pharmacotherapy. 1990; 10(4):301-4. PMID: 2117750.
      Citations:    
    33. White RL, Nightingale CH, Quintiliani R, Whitaker KF, Jones RF, Tripp WH. Serum and tissue concentrations of cefoxitin and cefotaxime in women undergoing hysterectomy. Drugs. 1988; 35 Suppl 2:72-7. PMID: 3396492.
      Citations:    
    34. Marchbanks CR, Yost RL, White RL. Cefotaxime stability during in vitro microbiological testing. Antimicrob Agents Chemother. 1987 Sep; 31(9):1375-8. PMID: 3314698.
      Citations:    
    White's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (168)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _